Saturday, July 12, 2014 11:29:41 AM
I will be very surprised if the share price isn't above .20 by Friday if the LymPro data is as positive as I expect it to be. There's a big difference between shorting 100,000 shares at .06 versus shorting 100,000 shares at .15 or higher especially when there are other milestones and catalysts that could occur at any time. Gerald did say that the company had six filings for grant funding currently in the pipeline.
Anyone selling here doesn't have a clue about what is about to happen.
Stay tuned for news.
:47-1:03 mark:
Twitter: @AmarantusBio .... 10,000 followers.
p.s. I'm holding on tight to my 112,000 shares.
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM